Givaudan Stock Falls After Jefferies Removes 'Buy' Rating in Favor of Rival Symrise

Shares of Givaudan SA (GIVN.SW) fell on Tuesday after an analyst at Jefferies removed a Buy recommendation on the stock, citing a strategic preference for a key European competitor. The move represents a direct rotation call within the flavors and fragrances sector, immediately weighing on investor sentiment.

Analyst Action Drives Sell-Off

The primary catalyst for the decline was a research note from Jefferies analyst Marcus Dunford-Castro. The note removed Givaudan from the bank's 'Buy' list while simultaneously upgrading its German rival, Symrise AG, to a Buy rating.

In response to the news, Givaudan's stock declined by 1.2% to CHF 3,242 during the session. The action signals to investors that the analyst sees a more favorable risk/reward profile in its competitor for the near term.

Pet Food Market a Key Differentiator

According to the Jefferies report, the rotation is based on the view that Symrise is better positioned to capitalize on the expanding market for pet food ingredients. The analyst identified this segment as an increasingly important growth vector and a key differentiator between the two companies.

Ad

This competitive analysis highlights a specific end-market where Givaudan is perceived to be at a relative disadvantage, influencing the stock's valuation compared to its peers.

Broader Context and Profitability Concerns

The downgrade comes as investors continue to assess Givaudan's recent performance. The company's first-half 2026 results had previously revealed a significant squeeze on both its net income and EBITDA margins, creating a headwind for the stock.

A cautious broader market backdrop, with major U.S. indices trading lower, added to the negative pressure. Givaudan's stock is currently trading well below its 52-week high of CHF 3,592 but remains above its 52-week low of CHF 2,566, indicating the market is still digesting the sector's recent re-rating.